Andres; Mark

Patent Applications and Registrations

Patent applications and USPTO patent grants for Andres; Mark.The latest application filed is for "selective inhibitor of protein arginine methyltransferase 5 (prmt5)".

Company Profile

7.17.28

Andres; Mark - West Lafayette IN
Andres; Mark - Bend OR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Solid forms of cannabidiol and uses thereof Grant 11,364,202 - Emanuele , et al. June 21, 2	2022-06-21
Selective Inhibitor Of Protein Arginine Methyltransferase 5 (prmt5) App 20220160713 - LIN; Hong ; et al.	2022-05-26
Crystalline Solvate Forms Of A Pharmaceutical App 20220002338 - White; Steven K. ; et al.	2022-01-06
Morphic Forms Of Complement Factor D Inhibitors App 20210332026 - Phadke; Avinash ; et al.	2021-10-28
Solid Forms Of Cannabidiol And Uses Thereof App 20210299048 - Emanuele; R. Martin ; et al.	2021-09-30
Crystalline solvate forms of a pharmaceutical Grant 10,995,112 - White , et al. May 4, 2	2021-05-04
Solid forms of an ASK1 inhibitor Grant 10,946,004 - Andres , et al. March 16, 2	2021-03-16
Crystalline Solvate Forms Of A Pharmaceutical App 20200190133 - White; Steven K. ; et al.	2020-06-18
Solid forms of cannabidiol and uses thereof Grant 10,604,467 - Emanuele , et al.	2020-03-31
Solid Forms Of An Ask1 Inhibitor App 20200061042 - Andres; Mark ; et al.	2020-02-27
New Solid Forms Of Cannabidiol And Uses Thereof App 20190300466 - Emanuele; R. Martin ; et al.	2019-10-03
New Solid Forms Of Cannabidiol And Uses Thereof App 20190177258 - Emanuele; R. Martin ; et al.	2019-06-13
Solid Forms Of An Ask1 Inhibitor App 20180243281 - Andres; Mark ; et al.	2018-08-30
Crystalline Solvate Forms Of A Pharmaceutical App 20180208623 - White; Steven K. ; et al.	2018-07-26
Treatment methods using pharmaceutical solid state forms Grant 9,877,972 - White , et al. January 30, 2	2018-01-30
Crystalline solvate forms of a pharmaceutical Grant 9,850,271 - White , et al. December 26, 2	2017-12-26
Crystalline solvate forms of a pharmaceutical App 20170152281 - White; Steven K. ; et al.	2017-06-01
Solid forms of an ASK1 inhibitor Grant 9,643,956 - Andres , et al. May 9, 2	2017-05-09
Crystalline anhydrate forms of a pharmaceutical Grant 9,555,046 - White , et al. January 31, 2	2017-01-31
Solid Forms Of An Ask1 Inhibitor App 20160280683 - Andres; Mark ; et al.	2016-09-29
Treatment Methods Using Pharmaceutical Solid State Forms App 20160175322 - White; Steven K. ; et al.	2016-06-23
Crystalline Anhydrate Forms Of A Pharmaceutical App 20160083415 - White; Steven K. ; et al.	2016-03-24
Treatment Methods Using Pharmaceutical Solid State Forms App 20160045516 - White; Steven K. ; et al.	2016-02-18
Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts Grant 9,150,567 - Song , et al. October 6, 2	2015-10-06
Substituted Tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine Salts App 20150197518 - Song; Jiangao ; et al.	2015-07-16
Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts Grant 8,815,886 - Song , et al. August 26, 2	2014-08-26
Substituted Tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine Salts App 20140038971 - SONG; Jiangao ; et al.	2014-02-06
Key intermediate for the preparation of Stilbenes, solid forms of Pterostilbene, and methods for making the same Grant 8,524,782 - Subbaraju , et al. September 3, 2	2013-09-03
Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts Grant 8,410,127 - Song , et al. April 2, 2	2013-04-02
Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-p- yrimidinyl]methyl]-benzonitrile Grant 8,324,383 - Andres , et al. December 4, 2	2012-12-04
Treatment Methods Using Pharmaceutical Solid State Forms App 20120302537 - White; Steven K. ; et al.	2012-11-29
Crystalline Anhydrate Forms Of A Pharmaceutical App 20120296105 - White; Steven K. ; et al.	2012-11-22
Solid state forms of a pharmaceutical Grant 8,252,947 - White , et al. August 28, 2	2012-08-28
Substituted Tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine Salts App 20110152270 - Song; Jiangao ; et al.	2011-06-23
Key Intermediate For The Preparation Of Stilbenes, Solid Forms Of Pterostilbene, And Methods For Making The Same App 20110144212 - Subbaraju; Gottumukkala V. ; et al.	2011-06-16
POLYMORPHS OF BENZOATE SALT OF 2-[[6-[(3r)-3-AMINO-1- PIPERIDINYL]-3,4-DIHYDRO-3- METHYL-2,4-DIOXO-1(2H)-PYRIMIDINYL]METHYL]-BENZONITRILE AND METHODS OF USE THEREFORE App 20090306379 - Andres; Mark ; et al.	2009-12-10
Solid State Forms Of A Pharmaceutical App 20090291933 - White; Steven K. ; et al.	2009-11-26
Polymorphs Of Benzoate Salt Of 2-[[6-[(3r)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2h)-p- Yrimidinyl]methyl]-benzonitrile And Methods Of Use Therefor App 20070066635 - Andres; Mark ; et al.	2007-03-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.